Bleeding and acute coronary syndromes: defining, predicting, and managing risk and outcomes.
Publication
, Journal Article
Halim, SA; Rao, SV
Published in: Curr Drug Targets
November 2011
Acute coronary syndromes (ACS) continue to have a large impact on morbidity and mortality in the United States. Over the last two decades, there have been several advancements in the care of patients with ACS. The use of combined antiplatelet and anticoagulants and early invasive risk stratification in high risk patients has improved the rates of major adverse cardiovascular events. However, this treatment strategy increases the risk for bleeding. Studies have found an association between bleeding and subsequent mortality and morbidity in ACS patients; therefore, minimizing bleeding risk has become a priority. This review describes the prevalence of bleeding during ACS management, risk for bleeding, and strategies to reduce bleeding risk.
Duke Scholars
Published In
Curr Drug Targets
DOI
EISSN
1873-5592
Publication Date
November 2011
Volume
12
Issue
12
Start / End Page
1831 / 1835
Location
United Arab Emirates
Related Subject Headings
- Risk Factors
- Platelet Aggregation Inhibitors
- Pharmacology & Pharmacy
- Incidence
- Humans
- Hemorrhage
- Fibrinolytic Agents
- Angioplasty, Balloon, Coronary
- Acute Coronary Syndrome
- 3214 Pharmacology and pharmaceutical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Halim, S. A., & Rao, S. V. (2011). Bleeding and acute coronary syndromes: defining, predicting, and managing risk and outcomes. Curr Drug Targets, 12(12), 1831–1835. https://doi.org/10.2174/138945011797635876
Halim, Sharif A., and Sunil V. Rao. “Bleeding and acute coronary syndromes: defining, predicting, and managing risk and outcomes.” Curr Drug Targets 12, no. 12 (November 2011): 1831–35. https://doi.org/10.2174/138945011797635876.
Halim SA, Rao SV. Bleeding and acute coronary syndromes: defining, predicting, and managing risk and outcomes. Curr Drug Targets. 2011 Nov;12(12):1831–5.
Halim, Sharif A., and Sunil V. Rao. “Bleeding and acute coronary syndromes: defining, predicting, and managing risk and outcomes.” Curr Drug Targets, vol. 12, no. 12, Nov. 2011, pp. 1831–35. Pubmed, doi:10.2174/138945011797635876.
Halim SA, Rao SV. Bleeding and acute coronary syndromes: defining, predicting, and managing risk and outcomes. Curr Drug Targets. 2011 Nov;12(12):1831–1835.
Published In
Curr Drug Targets
DOI
EISSN
1873-5592
Publication Date
November 2011
Volume
12
Issue
12
Start / End Page
1831 / 1835
Location
United Arab Emirates
Related Subject Headings
- Risk Factors
- Platelet Aggregation Inhibitors
- Pharmacology & Pharmacy
- Incidence
- Humans
- Hemorrhage
- Fibrinolytic Agents
- Angioplasty, Balloon, Coronary
- Acute Coronary Syndrome
- 3214 Pharmacology and pharmaceutical sciences